Urine from chronic hepatitis B virus carriers: Implications for infectivity

被引:1
|
作者
Knutsson, M [1 ]
Kidd-Ljunggren, K [1 ]
机构
[1] Univ Lund, Dept Infect Dis, S-22185 Lund, Sweden
关键词
HBV DNA; polymerase chain reaction; transmission; HBeAg; anti-HBe;
D O I
10.1002/(SICI)1096-9071(200001)60:1<17::AID-JMV3>3.0.CO;2-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Horizontal transmission of hepatitis B virus (HBV) without apparent sexual or parenteral exposure is common in hyperendemic areas. in most cases, the route of transmission is unknown. To investigate urine as a potential source of infection, serum and urine from 56 chronic hepatitis B surface antigen (HBsAg) carriers were examined for the presence of HBV DNA using the polymerase chain reaction (PCR). Thirty-four of the patients were anti-hepatitis B e antigen (anti-HBe) positive and 22 were hepatitis B e antigen (HBeAg) positive. HBV DNA was detected in serum from 46 patients (82%) and in urine from 28 patients (50%). Most HBeAg-positive patients had HBV DNA detectable in urine (91%), whereas urine samples from anti-HBe-positive patients were found to contain HBV DNA to a lesser extent (24%). When comparing HBV DNA from serum and urine by an end-point titration PCR, a titration difference averaging 10(3) was found between serum and urine. A significant female predominance was also noted among the positive urine samples (P < 0.05), which was not correlated to the presence of haematuria. Detection of HBV DNA may indicate active viral replication, and thereby infectivity. Because a high proportion of chronic HBV carriers were found to have HBV DNA in urine, it is suggested that irrespective of HBeAg/anti-HBe status, urine should be regarded as a potential route of transmission and therefore be investigated further as a means of horizontal and nosocomial transmission of HBV. J. Med. Virol. 60: 17-20, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [1] MARKERS OF HEPATITIS-B VIRUS-INFECTION IN URINE OF CHRONIC CARRIERS
    DIBISCEGLIE, AM
    DUSHEIKO, GM
    KEW, MC
    SOUTH AFRICAN MEDICAL JOURNAL, 1984, 65 (25): : 1025 - 1026
  • [2] INFECTIVITY OF HEPATITIS-B VIRUS (HBV) IN FAMILY CONTACTS OF CHRONIC ACTIVE HEPATITIS PATIENTS AND ASYMPTOMATIC CARRIERS
    NATH, N
    SANDLER, SG
    MAZZUR, S
    TRANSFUSION, 1978, 18 (05) : 648 - 648
  • [3] Hepatitis A vaccination in chronic carriers of hepatitis B virus
    Nebbia, G
    Giacchino, R
    Soncini, R
    Ramaccioni, V
    Timitilli, A
    Zanetti, AR
    JOURNAL OF PEDIATRICS, 1999, 134 (06): : 784 - 785
  • [4] DETECTION OF MARKERS OF HEPATITIS-B VIRUS-INFECTION IN URINE OF CHRONIC CARRIERS
    DIBISCEGLIE, AM
    DUSHEIKO, GM
    KEW, MC
    JOURNAL OF MEDICAL VIROLOGY, 1985, 16 (04) : 337 - 341
  • [5] INFECTIVITY MARKERS IN HBSAG CHRONIC CARRIERS AND INTRAFAMILIAL SPREAD OF HEPATITIS-B VIRUS-INFECTION
    PASTORE, G
    DENTICO, P
    ANGARANO, G
    LAPEDOTA, E
    SCHIRALDI, O
    HEPATO-GASTROENTEROLOGY, 1981, 28 (01) : 20 - 22
  • [6] Genotype of hepatitis B virus isolates from Iranian chronic carriers of the virus
    Vaezjalali, Maryam
    Alavian, Seyed-Moayed
    Jazayeri, Seyed Mohammad
    Nategh, Rakhshandeh
    Mahmoodi, Mahmood
    Hajibeigi, Bashir
    Azad, Talat Mokhtari
    HEPATITIS MONTHLY, 2008, 8 (02) : 97 - 100
  • [7] Aflatoxin M1 in the urine of non-carriers and chronic carriers of hepatitis B virus in Maringa, Brazil
    Giolo, Marcel Padovani
    de Oliveira, Christiane Minervino
    Bertolini, Dennis Armando
    Lonardoni, Maria Valdrinez Campana
    Gouveia, Matheus Sampaio
    Netto, Daisy Pontes
    Nixdorf, Suzana Lucy
    Machinski Junior, Miguel
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 48 (03) : 447 - 452
  • [8] Reduction of Infectivity in Chronic Hepatitis B Virus Carriers among Healthcare Providers and Pregnant Women by Antiviral Therapy
    Gerlich, Wolfram H.
    INTERVIROLOGY, 2014, 57 (3-4) : 202 - 211
  • [9] Therapeutic vaccination in chronic hepatitis B virus carriers
    Pol, Stanislas
    Michel, Marie-Louise
    EXPERT REVIEW OF VACCINES, 2006, 5 (05) : 707 - 716
  • [10] THE RELATIONSHIP BETWEEN INFECTIVITY OF SERUM FROM HEPATITIS-B VIRUS CARRIERS, ANTIVIRAL THERAPY, AND INTEGRATED HEPATITIS-B VIRUS-DNA
    SHAFRITZ, DA
    ARIAS, IM
    HEPATOLOGY, 1982, 2 (01) : 106 - 107